menu
    • menu

    Company profile for Kronos Bio

    NEW Drugs in Dev: 6
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kronos Bio is dedicated to the discovery and development of first-in-class therapies that modulate historically undruggable targets. We leverage deep capabilities in high-throughput small molecule microarrays (SMM), targeted protein degradation, and cancer biology in order to identify potent and selective compounds against transcription factors and other central drivers of oncogenic signaling.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kronos BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1300 So. El Camino Real Suite 300 San Mateo, CA 9440
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kronosbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/kronos-bio-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/kronosbio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Cosmoprof WW Bologna

    Cosmoprof WW Bologna

    Not Confirmed

    envelop Contact Supplier

    Cosmoprof WW Bologna

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ignota Labs Acquires Kronos's Clinical Pipeline
    Ignota Labs Acquires Kronos's Clinical Pipeline

    06 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251005158956/en/Ignota-Labs-Acquires-Kronoss-Clinical-Pipeline

    BUSINESSWIRE
    06 Oct 2025
    Share Share
    Concentra swoops in to purchase struggling Kronos
    Concentra swoops in to purchase struggling Kronos

    02 May 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/concentra-acquires-struggling-small-molecule-biotech-kronos

    FIERCE BIOTECH
    02 May 2025
    Share Share
    Kronos Bio Reports 2024 Financial Results
    Kronos Bio Reports 2024 Financial Results

    18 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2025/03/18/3044959/0/en/Kronos-Bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results.html

    GLOBENEWSWIRE
    18 Mar 2025
    Share Share
    Kronos Bio Announces CEO Transition and Reduction in Force
    Kronos Bio Announces CEO Transition and Reduction in Force

    27 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/27/2988138/0/en/Kronos-Bio-Announces-CEO-Transition-and-Reduction-in-Force.html

    GLOBENEWSWIRE
    27 Nov 2024
    Share Share
    Kronos lays off 83% of staff, changes CEO after clinical setback
    Kronos lays off 83% of staff, changes CEO after clinical setback

    27 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kronos-telegraphs-layoffs-and-ceo-shakeup-after-mothballing-lone-clinical-asset

    FIERCE BIOTECH
    27 Nov 2024
    Share Share
    Kronos shelves sole clinical drug over neurological side effects
    Kronos shelves sole clinical drug over neurological side effects

    14 Nov 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/kronos-shelves-sole-remaining-clinical-asset-over-neurological-side-effects

    FIERCE BIOTECH
    14 Nov 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search